Todd Shryock

Collaboration will build Lumeris’ Tom platform on Google Cloud’s AI infrastructure, with the goal of increasing access to high-quality primary care for millions of Americans.

Results show the device significantly improved symptoms of nasal obstruction in patients with nasal septal deviation

The FDA’s IDE approval allows Presidio to initiate a randomized, controlled trial in the United States and Australia to evaluate the safety and efficacy of its ULF neuromodulation technology

The novel test uses a machine learning algorithm and multiple cardiac protein markers to detect obstructive coronary artery disease through a simple blood draw.

Company eyes FDA clearance for expanding use of real-time navigation technology

Having a DCES on staff helps, but virtual options are also effective

2,000 consumers offered their feedback on medical devices. Here are the findings.

Phillips Medisize announces its new TheraVolt connectors, enhancing EP device performance and integration for advanced cardiac treatments like pulsed field ablation.

Reports will assess providers' capabilities in digital engineering, product development, regulatory compliance, and post-market digital services, with a focus on addressing key challenges such as data interoperability and cybersecurity.

The selected startups represent the top 4% of nearly 1,500 applicants from around the globe and will participate in MTI’s flagship four-month program focused on de-risking innovation and fast-tracking market access in the U.S.

A cardiologist, chef and food researcher discusses a new major analysis of American health and nutrition.

A discussion with Duke University's Mark McClellan, M.D., Ph.D., about why value-based care hasn’t been adopted more quickly

Openwater's portable stroke detection tool enhances EMS capabilities, improving rapid diagnosis and treatment for severe strokes in emergency settings.

Guardant Health's Shield multi-cancer screening test detects multiple cancer types with a single blood draw, promising early diagnosis for various cancers.

BiVACOR's magnetic artificial heart gains FDA Breakthrough Device status, promising a revolutionary solution for severe heart failure patients.

Reflow Medical's Spur Stent System gains FDA clearance, offering treatment options for chronic limb-threatening ischemia with its retrievable design.

Key inflation gauge increased 0.1% for the month, putting the annual rate at 2.1%

Aledade and ACOs press CMS to fix benchmarking error that could slash shared savings

Moximed initiates a trial for its MISHA Knee System, an alternative treatment for knee osteoarthritis, promising pain relief and improved mobility.

Company expects to submit to FDA in 2026

GlobalData report says hospitals may be accelerating purchases of certain medical devices

Tenovi's new blood pressure monitor enhances stroke prevention by enabling early detection of hypertension and irregular heartbeats through remote patient monitoring.

Aptar Digital Health and AstraZeneca collaborate to revolutionize chronic kidney disease detection using AI algorithms in eye exams, enhancing early diagnosis.

Medtronic announces a diabetes business spinoff to enhance focus on growth areas, aiming for improved financial performance and shareholder value.

ReGelTec's HYDRAFIL System offers a minimally invasive treatment for chronic low back pain, promising significant pain relief and improved function.

Atia Vision's OmniVu lens system promises a breakthrough in cataract surgery with enhanced vision restoration.

U.S. tariffs are disrupting European medtech growth, forcing firms to adapt supply chains and prioritize cost optimization amid rising challenges and uncertainties.

Artificial intelligence (AI) is rapidly reshaping the landscape of health care, from streamlining administrative tasks to aiding in complex clinical decision-making. Tools powered by AI are being used to interpret imaging scans, predict patient deterioration, assist in diagnosis, and personalize treatment plans. While the technology holds enormous promise for improving efficiency, accuracy, and outcomes, its success depends heavily on the trust it earns from both health care providers and patients.

The VivAer procedure offers lasting relief for nasal obstruction, transforming NAO treatment with its minimally invasive approach and impressive results.

Medtech CEO warns senate that tariffs could undermine health care and innovation